Emmes

Orphan Reach is a global clinical research organization (CRO) specializing in services for rare diseases. The company has established a strong reputation for its comprehensive clinical development capabilities, guiding clients from early patient trials to marketing authorization. Orphan Reach offers a wide range of services, including project management, clinical monitoring, safety and pharmacovigilance, quality assurance, data management, and biostatistics, all tailored to meet the specific needs of its clients. The organization focuses on addressing the unique challenges associated with rare diseases, particularly those involving small patient populations. By providing bespoke solutions that adapt to the requirements of orphan drug developers, Orphan Reach enhances the drug development process, ensuring that researchers can effectively navigate the complexities of bringing innovative treatments to market.

Neox s.r.o. is a contract research organization based in Prague, Czechia, that provides comprehensive clinical research support services. Established in 1995, Neox specializes in conducting clinical trials for pharmaceutical, biotechnology, and medical device companies across Europe and the United States. The organization offers a wide range of services covering all phases of drug development, including medical writing, site contracting, clinical monitoring, project management, pharmacovigilance, and regulatory support. Neox also caters to medical device development and real-world evidence/data management. With years of experience and an understanding of local requirements, the company emphasizes optimal trial settings to enhance patient enrollment. Neox operates in multiple countries, including Austria, Belgium, Germany, and the United Kingdom, ensuring a broad geographical reach for its clinical research activities. As of December 2020, Neox serves as a subsidiary of The Emmes Company, LLC.